174 related articles for article (PubMed ID: 5593108)
1. [Practical experiences with a hydroquinone monobenzylether preparation and a sunscreening agent in hyperpigmentations and light dermatoses].
Jung HD
Z Haut Geschlechtskr; 1967 Sep; 42(17):711-6. PubMed ID: 5593108
[No Abstract] [Full Text] [Related]
2. [On the problem of lightprotection and the therapy of light dermatoses].
Tronnier H
Dermatol Wochenschr; 1966 Mar; 152(13):313-30. PubMed ID: 5974132
[No Abstract] [Full Text] [Related]
3. [Protective ointments against occupational photosensitization due to tar containing substances].
Wiskemann A; Krempin I
Berufsdermatosen; 1967 Aug; 15(4):208-12. PubMed ID: 4231941
[No Abstract] [Full Text] [Related]
4. [Practical dermatologic viewpoints on light protection and depigmentation].
Tronnier H; Hoppe-Seyler G
Asthet Med (Berl); 1968 Oct; 17(10):221-8. PubMed ID: 5306151
[No Abstract] [Full Text] [Related]
5. Pediatric photosensitivity disorders.
Pacha O; Hebert AA
Dermatol Clin; 2013 Apr; 31(2):317-26. PubMed ID: 23557658
[TBL] [Abstract][Full Text] [Related]
6. [The prevention of photodermatoses].
Longhin S
Dermatol Int; 1965; 4(3):192-6. PubMed ID: 5877289
[No Abstract] [Full Text] [Related]
7. Treatment of nonhairy melanocytic macules by dermabrasion and topical application of 5% hydroquinone monobenzyl ether cream.
Tezuka T; Saheki M; Kusuda S; Umemoto K
J Am Acad Dermatol; 1993 May; 28(5 Pt 1):771-2. PubMed ID: 8496423
[No Abstract] [Full Text] [Related]
8. Topical and systemic approaches to photoprotection.
Fitzpatrick TB; Pathak MA; Parrish JA; Mathews-Roth M
Proc R Soc Med; 1971 Aug; 64(8):861-2. PubMed ID: 5569329
[No Abstract] [Full Text] [Related]
9. [Experience in the treatment of hyperpigmentation of facial skin with hydroquinone monobenzyl ether].
Gusarova AS; Zalem ZIa
Vestn Dermatol Venerol; 1966 Mar; 40(3):49-52. PubMed ID: 5988245
[No Abstract] [Full Text] [Related]
10. Beta-carotene as a photoprotective agent in erythropoietic protoporphyria.
Mathews-Roth MM; Pathak MA; Fitzpatrick TB; Harber LC; Kass EH
Trans Assoc Am Physicians; 1970; 83():176-84. PubMed ID: 5505388
[No Abstract] [Full Text] [Related]
11. [Treatment of hyperpigmentation with hydroquinone monobenzylether ointment].
LANGHOF H; ZABEL R
Z Haut Geschlechtskr; 1959 May; 26(9):274-7. PubMed ID: 13669571
[No Abstract] [Full Text] [Related]
12. Sunscreens for chloasma.
Wolfe EM
JAMA; 1969 Jul; 209(1):112. PubMed ID: 5819253
[No Abstract] [Full Text] [Related]
13. Use of hydroquinone as a bleaching cream.
Yi K; Hart LL
Ann Pharmacother; 1993 May; 27(5):592-3. PubMed ID: 8347912
[No Abstract] [Full Text] [Related]
14. [Dyschromia caused by monobenzylether of hydroquinone].
KAMINSKY A; DAITSCH J
Rev Asoc Med Argent; 1959 Oct; 73():419-21. PubMed ID: 13853226
[No Abstract] [Full Text] [Related]
15. [Therapy of melanin-induced pigment anomalies].
Herzberg JJ
Hautarzt; 1985 Nov; 36(11):635-8. PubMed ID: 3908403
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hyperpigmentations of the skin with hydroguinone (depigmentation ointment)].
Peisert E; Król C
Przegl Dermatol; 1972; 59(2):205-9. PubMed ID: 5023356
[No Abstract] [Full Text] [Related]
17. [Leucodermia acquisita areata caused by monobenzylether of hydroquinone (author's transl)].
Hegyi E; Valková P; Mat'oska J
Cesk Dermatol; 1979 Feb; 54(1):6-8. PubMed ID: 761240
[No Abstract] [Full Text] [Related]
18. Skin bleaching: highlighting the misuse of cutaneous depigmenting agents.
Dadzie OE; Petit A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):741-50. PubMed ID: 19470077
[TBL] [Abstract][Full Text] [Related]
19. Lupus erythematosus tumidus: an underestimated entity.
Teixeira M; Ferreira M; Alves R; Selores M
Lupus; 2006; 15(5):296-300. PubMed ID: 16761505
[TBL] [Abstract][Full Text] [Related]
20. Topical use of hydroquinone for depigmentation.
Spencer MC
JAMA; 1965 Nov; 194(9):962-4. PubMed ID: 5897964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
